Superworth

vTv Therapeutics EPS VTVT

Diluted earnings per share by quarter and over the last twelve months, from 2015.

Last 12 months, to Jun 30, 2026
−$1.06
Latest quarter, Q2 FY26
−$1.05
Fiscal year 2025
−$3.35

vTv Therapeutics' earnings per share was −$1.06 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.05.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$3.35n/a
FY2024−$3.41n/a
FY2023−$9.71n/a
FY2022−$10.00n/a
FY2021−$8.80n/a
FY2020−$7.60n/a
FY2019−$24.80n/a
FY2018−$30.80n/a
FY2017−$66.80n/a
FY2016−$68.80n/a
FY2015n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$1.05n/a−$1.06
Q1 FY26$1.65n/a−$0.93
Q4 FY25−$0.58n/a−$3.35
Q3 FY25−$1.08n/a−$3.32
Q2 FY25−$0.92n/a−$3.12
Q1 FY25−$0.77n/a−$3.01
Q4 FY24−$0.55n/a−$3.41
Q3 FY24−$0.88n/a−$4.53
Q2 FY24−$0.81n/a−$6.84
Q1 FY24−$1.17n/a−$8.72
Q4 FY23−$1.67n/a−$9.71
Q3 FY23−$3.19n/a−$10.44

Against its peers

Companies in Drug Manufacturers - General nearest vTv Therapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
VTVTvTv Therapeutics−$1.06
LFVNLifevantage$0.40−46% a year
SPROSpero Therapeutics$0.11
ATNMActinium Pharmaceuticals$0.36
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
Peer median$0.65

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on vTv Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.